• Developments and Challenges in the Therapeutic Landscape of Chronic Myeloid Leukemia

  • Jul 27 2023
  • Length: 20 mins
  • Podcast

Developments and Challenges in the Therapeutic Landscape of Chronic Myeloid Leukemia

  • Summary

  • Drs Michael J. Mauro and Jorge E. Cortes discuss developments in the therapeutic landscape of chronic myeloid leukemia, complexities of resistance, and the potential for treatment-free remission.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989026). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Chronic Myelogenous Leukemia (CML) https://emedicine.medscape.com/article/199425-overview

    Tyrosine Kinase Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK563322/

    Chronic Myelogenous Leukemia (CML) Treatment Protocols https://emedicine.medscape.com/article/2005453-overview

    Monitoring Molecular Response in Chronic Myeloid Leukemia https://pubmed.ncbi.nlm.nih.gov/20960522/

    Accelerated Phase Chronic Myelogenous Leukemia https://www.cancer.gov/publications/dictionaries/cancer-terms/def/accelerated-phase-chronic-myelogenous-leukemia

    The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms https://pubmed.ncbi.nlm.nih.gov/35732831/

    International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating Morphologic, Clinical, and Genomic Data https://pubmed.ncbi.nlm.nih.gov/35767897/

    International Chronic Myeloid Leukemia Foundation https://www.cml-foundation.org/

    Sokal Score for CML https://reference.medscape.com/calculator/559/sokal-score-for-cml

    Treatment-Free Remission: The New Goal in CML Therapy https://pubmed.ncbi.nlm.nih.gov/34618317/

    Hematopoietic Stem Cell Transplantation (HSCT) https://emedicine.medscape.com/article/208954-overview

    Imatinib (Rx) https://reference.medscape.com/drug/gleevec-imatinib-342239

    BCR-ABL Fusion Gene https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bcr-abl-fusion-gene

    Ph-like Acute Lymphoblastic Leukemia https://pubmed.ncbi.nlm.nih.gov/28972016/

    Next-Generation Sequencing for BCR-ABL1 Kinase Domain Mutation Testing in Patients With Chronic Myeloid Leukemia: A Position Paper https://pubmed.ncbi.nlm.nih.gov/31801582/

    ASXL1 Gene https://medlineplus.gov/genetics/gene/asxl1/

    Asciminib https://reference.medscape.com/drug/scemblix-asciminib-4000255

    The Specificity of Asciminib, a Potential Treatment for Chronic Myeloid Leukemia, as a Myristate-Pocket Binding ABL Inhibitor and Analysis of Its Interactions With Mutant Forms of BCR-ABL1 Kinase https://pubmed.ncbi.nlm.nih.gov/33096322/

    ATP-Competitive Inhibitors Modulate the Substrate Binding Cooperativity of a Kinase by Altering Its Conformational Entropy https://pubmed.ncbi.nlm.nih.gov/35905186/

    Ponatinib (Rx) https://reference.medscape.com/drug/iclusig-ponatinib-999800

    Show More Show Less
activate_samplebutton_t1

What listeners say about Developments and Challenges in the Therapeutic Landscape of Chronic Myeloid Leukemia

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.